GLP-1 receptor agonists (GLP-1RAs) are chemical structures, largely based on peptides, that can mimic GLP-1 hormone through binding to key receptors in the body, producing the same effects
These medications are administered either as subcutaneous injections (daily or weekly, depending on the formulation) or, in the case of semaglutide (Rybelsus), as an oral tablet
This guide breaks down the comparison across every dimension that matters to someone deciding which peptide to work with
These tend to be most prominent during dose escalation and often improve over time as the body adapts
Eating smaller, frequent meals instead of three large meals also helps prevent overwhelming your digestive system
Your pancreatic beta cells require time to optimize their insulin response patterns